Carlos Rojas, MD

home / authors / carlos-rojas-md

Carlos Rojas, MD, is a medical oncologist and executive director of the Centro de Investigacion Clinica, Bradford Hill, in Santiago, Chile.

Articles

About the Continued Evaluation of MK-1084 for NSCLC and More

Carlos Rojas, MD

March 20th 2024

Carlos Rojas, MD, discusses the next steps for evaluating MK-1084 in a phase 1 trial for the first-line treatment of metastatic non-small cell lung cancer and advanced solid tumors.

Overview of the Mechanism of Action of MK-1084

Carlos Rojas, MD

March 13th 2024

Carlos Rojas, MD, discusses the mechanism of action of MK-1084, a selective KRAS G12C inhibitor.

Preliminary Data of MK-1084 +/- Pembrolizumab in Solid Tumors and NSCLC

Carlos Rojas, MD

November 17th 2023

Carlos Rojas, MD, discusses preliminary findings from a phase 1 trial which of MK-1084 alone and with pembrolizumab in patients with advanced solid tumors and metastatic non–small cell lung cancer.